Predicting human microRNA-disease associations based on support vector machine
暂无分享,去创建一个
[1] M. Wood,et al. Short non-coding RNA biology and neurodegenerative disorders: novel disease targets and therapeutics. , 2009, Human molecular genetics.
[2] Byoung-Tak Zhang,et al. miTarget: microRNA target gene prediction using a support vector machine , 2006, BMC Bioinformatics.
[3] Doheon Lee,et al. Predicting disease phenotypes based on the molecular networks with Condition-Responsive Correlation , 2011, Int. J. Data Min. Bioinform..
[4] Alexander Gammerman,et al. Sequence alignment kernel for recognition of promoter regions , 2003, Bioinform..
[5] Xiaoyan Zhu,et al. Discovering breast cancer drug candidates from biomedical literature , 2010, Int. J. Data Min. Bioinform..
[6] Vladimir Cherkassky,et al. The Nature Of Statistical Learning Theory , 1997, IEEE Trans. Neural Networks.
[7] Michael Q. Zhang,et al. Network-based global inference of human disease genes , 2008, Molecular systems biology.
[8] Yadong Wang,et al. miR2Disease: a manually curated database for microRNA deregulation in human disease , 2008, Nucleic Acids Res..
[9] Pall I. Olason,et al. A human phenome-interactome network of protein complexes implicated in genetic disorders , 2007, Nature Biotechnology.
[10] Fei Li,et al. Classification of real and pseudo microRNA precursors using local structure-sequence features and support vector machine , 2005, BMC Bioinformatics.
[11] C. Croce,et al. MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.
[12] Michael Kertesz,et al. The role of site accessibility in microRNA target recognition , 2007, Nature Genetics.
[13] Tyler E. Miller,et al. MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1*♦ , 2008, Journal of Biological Chemistry.
[14] Robert A. Weinberg,et al. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer (Nature (2007) 449, (682-688)) , 2008 .
[15] Alan F. Scott,et al. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders , 2002, Nucleic Acids Res..
[16] F. Slack,et al. MicroRNA in cancer prognosis. , 2008, The New England journal of medicine.
[17] Rosario M. Piro,et al. Prediction of Human Disease Genes by Human-Mouse Conserved Coexpression Analysis , 2008, PLoS Comput. Biol..
[18] G. Vriend,et al. A text-mining analysis of the human phenome , 2006, European Journal of Human Genetics.
[19] Nitai P. Bhattacharyya,et al. MicroRNA Interaction network in human: implications of clustered microRNA in biological pathways and genetic diseases , 2009, 0901.4211.
[20] Yi Xing,et al. The Bifunctional microRNA miR-9/miR-9* Regulates REST and CoREST and Is Downregulated in Huntington's Disease , 2008, The Journal of Neuroscience.
[21] Vassilis Georgoulias,et al. Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR. , 2008, Clinical chemistry.
[22] Q. Cui,et al. An Analysis of Human MicroRNA and Disease Associations , 2008, PloS one.
[23] William Stafford Noble,et al. Kernel methods for predicting protein-protein interactions , 2005, ISMB.
[24] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[25] C. Burge,et al. Prediction of Mammalian MicroRNA Targets , 2003, Cell.
[26] Ziv Bar-Joseph,et al. Evaluation of different biological data and computational classification methods for use in protein interaction prediction , 2006, Proteins.
[27] E. Miska,et al. How microRNAs control cell division, differentiation and death. , 2005, Current opinion in genetics & development.
[28] R. Duisters,et al. MIRNA-133 AND MIRNA-30 REGULATE CONNECTIVE TISSUE GROWTH FACTOR: IMPLICATIONS FOR A ROLE OF MIRNAS IN MYOCARDIAL MATRIX REMODELING , 2013 .
[29] Yadong Wang,et al. Prioritization of disease microRNAs through a human phenome-microRNAome network , 2010, BMC Systems Biology.
[30] Aimee L Jackson,et al. Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215. , 2008, Cancer research.